Broadfin Capital’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-123,785	Closed	-$3.44M	–	43
2019 Q2	$3.44M	Sell	123,785 -116,215	-48%	-$3.23M	0.75%	30
2019 Q1	$7.97M	Buy	+240,000	New	+$7.97M	1.65%	24